d.87 |
DA de Luis, E Romero. Análogos de la insulina:modificaciones en la estructura, consecuencias moleculares y metabólicas. Semergen 2013;39:34-40 |
· |
d.88 |
DA de Luis, O Izaola, B de la Fuente, K Araujo. Respuesta glucemia e insulinemica a dos formulas enteales isocaloricas en pacientes con diabetes mellitus tipo 2 Nutr Hosp 2013; 28;78-85 FI1,305 |
· |
d.89 |
DA de Luis, O Izaola, B de la Fuente, MC Terroba, L Cuellar. A randomized clinical trial with two doses of an enteral diabetes-specific supplements in elderly patients with diabetes mellitus type 2. European Review for Med and Phamracol Sci 2013;17:1626-1630. FI 1,093 |
· |
d.90 |
Da de Luis, R Aller, R Conde, O Izaola, B de l Fuente, M Gonzalez. Relation of the rs9939609 gene variant in FTO with metabolic síndrome in obese female patients. Journal of Diabetes and its complications 2013;27;346-350. FI 2.056 |
· |
d.91 |
DA de Luis, M Goznalez, R Conde, R Aller, O Izaola. Relation of visfatin to cardiovascular risk factors and adipokines in patients with impaired fasting glucose. Nutrition 2013;29:1300-1303. FI2.86 |
· |
d.92 |
DA de Luis, R Aller, M Gonzalez, R COnde, O Izaola, B de la Fuente. Serum visfatin levels and metabolic síndrome criteria in obese females subjects. Diabetes metab Research and reviews 2013;29:576-581. . FI2,968 |
· |